Hematological disorders and diagnostics
Hematological disorders and diagnostics is a research topic within Emergency Medicine. Science Explorer counts 28k research works in it since 1950. 7.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnostic approach to fever of unknown origin (FUO), with a particular emphasis on the use of FDG PET/CT imaging, bone marrow biopsy, and the evaluation of pancytopenia. It encompasses studies on the clinical evaluation, etiological profile, and diagnostic algorithms for identifying the cause of FUO, often related to inflammation and hematological malignancies. The cluster includes numerous prospective studies, meta-analyses, and systematic reviews highlighting the importance of these diagnostic tools in managing patients with FUO.
- FDG PET/CT
- Bone Marrow Biopsy
- Pancytopenia
- Inflammation
- Diagnostic Algorithm
- Etiological Profile
- Hematological Malignancy
- Clinical Evaluation
- Meta-Analysis
- Prospective Study
- Research works
- 28k fractional, since 1950
- In the world top 10%
- 2.2k per year above
- Top-10% rate
- 7.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +27% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Hematological disorders and diagnostics research?
By volume, the United States and India publish the most (785 and 459 works in 2022–2025).
By volume, 2022–2025
- 1 United States 785 works
- 2 India 459 works
- 3 China 397 works
- 4 Germany 169 works
- 5 United Kingdom 152 works
- 6 Japan 148 works
- 7 Türkiye 128 works
- 8 Italy 109 works
- 9 Spain 106 works
- 10 Brazil 105 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Hematological disorders and diagnostics research?
By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Hematological disorders and diagnostics research, followed by Post Graduate Institute of Medical Education and Research and The University of Texas MD Anderson Cancer Center.
By volume, 2022–2025
- 1 All India Institute of Medical SciencesIndia 18 works
- 2 Post Graduate Institute of Medical Education and ResearchIndia 16 works
- 3 The University of Texas MD Anderson Cancer CenterUnited States 15 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 14 works
- 5 Institute of Medical SciencesIndia 12 works
- 6 Sağlık Bilimleri ÜniversitesiTürkiye 11 works
- 7 Charité - Universitätsmedizin BerlinGermany 10 works
- 8 Ain Shams UniversityEgypt 10 works
- 9 Mayo Clinic in ArizonaUnited States 9 works
- 10 Massachusetts General HospitalUnited States 8 works
Who are the leading researchers in Hematological disorders and diagnostics?
The most-cited researchers publishing on Hematological disorders and diagnostics include Winfried März and Thomas Schwarz.
- 1 Winfried März Germany 5.2k citations
- 2 Thomas Schwarz United States 3.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Hematological disorders and diagnostics research done?
The largest centres of Hematological disorders and diagnostics research in 2022–2025 are Beijing (China), London (United Kingdom), New Delhi (India) and Istanbul (Türkiye).
Largest cities, 2022–2025
Where is the best place to study Hematological disorders and diagnostics?
Among universities, judged by research, Post Graduate Institute of Medical Education and Research, Institute of Medical Sciences and All India Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Post Graduate Institute of Medical Education and ResearchIndia | 53.4 | 5.6% | 13.4× | 16 | +36.6% |
| 2 | Institute of Medical SciencesIndia | 52.2 | 0.2% | 10.3× | 12 | +206.6% |
| 3 | All India Institute of Medical SciencesIndia | 46.8 | 2.1% | 8.0× | 18 | +61.3% |
| 4 | Johns Hopkins UniversityUnited States | 39.8 | 21.6% | 2.0× | 8 | +22.5% |
| 5 | Sağlık Bilimleri ÜniversitesiTürkiye | 37.7 | 3.0% | 5.4× | 11 | — |
| 6 | Ain Shams UniversityEgypt | 35.5 | 4.6% | 3.7× | 10 | +271.6% |
| 7 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 33.2 | 4.7% | 3.9× | 14 | +46.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Hematological disorders and diagnostics research growing?
Output in 2018–2022 was 27% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Hematological disorders and diagnostics.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.